scanance.
Sign inGet Premium
PH

Phreesia, Inc.

PHRHealthcareNASDAQ

Health Information Services · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot
MA150-34.05%
$14.33

Price below medium-term moving average.

MA200-45.09%
$17.21

Below long-term trend line.

RSI-14neutral
44.2

Balanced. Not overbought, not oversold.

MACDpositive
+0.0331

Histogram positive — upward momentum.

Financials · Annual
Revenue
$480.6M
+14.5% YoY
Net Income
$2.3M
+103.9% YoY
EBITDA
$29.5M
+215.2% YoY
Free Cash Flow
$55.7M

Scan Results

Daily timeframe

1 of 4 indicators bullish as of May 28

DateIndicatorDetails
Loading...
About Phreesia, Inc.

Headquartered within the healthcare sector, Phreesia, Inc. focuses on Health Information Services services and products. Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company carries a $583.8M market cap, placing it firmly in the small-cap category. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions.

Key stats
Market Cap$583.8M
P/E (TTM)59.06
Fwd P/E5.76
EPS$0.16
Beta0.89
52W Change-61.4%
ROE0.8%
Analysis

On the balance sheet, PHR has $72.1M in cash with $102.4M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $55.7M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 0.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 0.3% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $280.9M (2023) to $480.6M (2026), reflecting a 71% increase over the period.

At over 50x earnings, PHR carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Phreesia, Inc. and its sector.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms